Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double-blind placebo-controlled trial of Z102 in moderate to severe rheumatoid arthritis
2011-000436-28Phase 2Completed
- Sponsor
- CombinatoRx
- Start
- Jun 2011
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of prednisolone + dipyridamole in rheumatoid arthritis (RA) (5 arms), sponsored by CombinatoRx. Primary endpoint: Change from baseline in DAS28-CRP at 12 weeks. Started Jun 2011; status: completed.
02
Drugs
prednisolone + dipyridamole
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2011-000436-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-000436-28.